All lobbying filings
CAPITOL HILL CONSULTING GROUP
CAPITOL HILL CONSULTING GROUP filed a Q3 report for HUMACYTE on October 20, 2026, reporting $50,000 in lobbying income.
Lobbying for HUMACYTE · Biotechnology platform for vascular diseases.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
North Carolina
Lobbyists on this filing
3
-
BRIAN SUTTERPreviously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
-
CHRISTOPHER DAVISPreviously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).
-
EMILY ELIZABETH WILKINSON-HOLLANDPreviously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
Government bodies contacted
4
Lobbying activity
3
Issues related to Medicare reimbursement for biological products.
Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.
Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.